OncoCyte IMDX
Oncocyte Announces Oral Presentation of New Data on Its DetermaIO™ Immunotherapy
- Form
- 8-K
- Filed
- Period
- Importance
- Routine
- Accession
- 0001493152-21-023121
- Document
- 8-K
- Exhibit 99.1
- Press release
- Discloses other events (8.01)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2835 and related industry codes: the same peer list as the financial tables.
- Rein Therapeutics RNTX public float $32M, Jun 30, 2025
- Yarrow Bioscience VYNE public float $32M, Jun 30, 2025
- Kezar Life Sciences KZR public float $33M, Jun 30, 2025
- Scorpius Holdings SCPX
- Provectus Biopharmaceuticals PVCT public float $31M, Jun 30, 2025
